Search research articles
Contact Us
Filters
Showing results (211-220 of 233) with videos related to
Page
of 24
Sort By:
The EMBO Journal
|
June 13, 2022
Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061
Gianmatteo Vit, Joana Duro, Girish Rajendraprasad, et al.
Nature Communications
|
July 2, 2026
VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Oluwatobi Andrew Adeosun, Christian Schröer, Elisabeth Südhoff, et al.
Cell Reports Methods
|
April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>
Kouki Matsuda, Saiful Islam, Toru Takada, et al.
Emerging Infectious Diseases
|
July 27, 2002
Genetic characterization of hantaviruses transmitted by the Korean field mouse (Apodemus peninsulae), Far East Russia
Kumari Lokugamage, Hiroaki Kariwa, Daisuke Hayasaka, et al.
Elife
|
September 14, 2022
Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
Tolulope Sokoya, Jan Parolek, Mads Møller Foged, et al.
Life (Basel, Switzerland)
|
June 24, 2022
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
Noriko Tomita, Sho Saito, Junko Terada-Hirashima, et al.
Molecular Systems Biology
|
December 2, 2010
A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae
Oriol Gallego, Matthew J Betts, Jelena Gvozdenovic-Jeremic, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 10, 2021
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals
Kenji Maeda, Masayuki Amano, Yukari Uemura, et al.
GHM Open
|
March 27, 2025
Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: A single-center, open-label, single-arm, interventional study in Japan
Satoshi Kutsuna, Sho Saito, Yuki Takamatsu, et al.
Scientific Reports
|
November 25, 2021
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
Kenji Maeda, Masayuki Amano, Yukari Uemura, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 233) with videos related to
Sort By:
Page
of 24
The EMBO Journal
|
June 13, 2022
Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061
Gianmatteo Vit, Joana Duro, Girish Rajendraprasad, et al.
Nature Communications
|
July 2, 2026
VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Oluwatobi Andrew Adeosun, Christian Schröer, Elisabeth Südhoff, et al.
Cell Reports Methods
|
April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>
Kouki Matsuda, Saiful Islam, Toru Takada, et al.
Emerging Infectious Diseases
|
July 27, 2002
Genetic characterization of hantaviruses transmitted by the Korean field mouse (Apodemus peninsulae), Far East Russia
Kumari Lokugamage, Hiroaki Kariwa, Daisuke Hayasaka, et al.
Elife
|
September 14, 2022
Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
Tolulope Sokoya, Jan Parolek, Mads Møller Foged, et al.
Life (Basel, Switzerland)
|
June 24, 2022
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
Noriko Tomita, Sho Saito, Junko Terada-Hirashima, et al.
Molecular Systems Biology
|
December 2, 2010
A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae
Oriol Gallego, Matthew J Betts, Jelena Gvozdenovic-Jeremic, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 10, 2021
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals
Kenji Maeda, Masayuki Amano, Yukari Uemura, et al.
GHM Open
|
March 27, 2025
Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: A single-center, open-label, single-arm, interventional study in Japan
Satoshi Kutsuna, Sho Saito, Yuki Takamatsu, et al.
Scientific Reports
|
November 25, 2021
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
Kenji Maeda, Masayuki Amano, Yukari Uemura, et al.
Page
of 24